EDGAR Filing Documents for 0001144204-14-033321

Form 8-K - Current report:

SEC Accession No. 0001144204-14-033321

Filing Date

2014-05-23

Accepted

2014-05-23 12:46:24

Documents

Period of Report

2014-05-21

Items

Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	v379683_8k.htm	8-K	29096
2	EXHIBIT 3.1	v379683_ex3-1.htm	EX-3.1	11039
3	EXHIBIT 99.1	v379683_ex99-1.htm	EX-99.1	8635
4	GRAPHIC	tex3-1.jpg	GRAPHIC	7005
5	GRAPHIC	tex99-1.jpg	GRAPHIC	12674
	Complete submission text file	0001144204-14-033321.txt		77358

Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647

Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646

ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)